Mental Health for the Masses: The Potential and Pitfalls of Scaling Psychedelic-Assisted Therapy
Listen & Subscribe:
LISTEN NOW: Mental Health for the Masses: The Potential and Pitfalls of Scaling Psychedelic-Assisted Therapy
〰️
LISTEN NOW: Mental Health for the Masses: The Potential and Pitfalls of Scaling Psychedelic-Assisted Therapy 〰️
Mental Health for the Masses
The Potential and Pitfalls of Scaling Psychedelic-Assisted Therapy with Dr. Dominique Morisano and Sonia Stringer
When people learn about the benefits of psychedelic-assisted therapy and how it helps those suffering with anxiety, depression, PTSD, chronic pain and other health issues, it’s easy to understand why there’s growing enthusiasm to make these treatments available to as many people as possible.
That’s certainly one reason that ketamine clinics are quickly growing in number in cities around the world.
There’s great potential, but also some real pitfalls, to making psychedelic-assisted therapy available to the masses, and in this episode we’ll examine some important considerations, including:
How to know when it’s time to scale? What are the critical questions and “kpi metrics” clinic owners should consider before scaling their psychedelic therapy services to other locations?
What types of clinicians should you hire? What are the best ways to find and hire skilled therapists who can deliver psychedelic therapy within specific time limits, without compromising on quality of care?
In terms of a therapeutic model for psychedelic therapy, what’s the best ratio of prep time to session time to integration time?
How important is it for a therapist to have experienced psychedelic-therapy themselves in order to do this work?
What are the key questions clinic owners and investors should be asking to know if they’re scaling for the right reasons?
If running on a limited budget, what elements should be prioritized within a psychedelic clinic (and which are not as important to its overall profitability or customer experience)?
As you bring on more clients and expand your services, what strategies can you utilize within a clinic to ensure your therapy staff won’t burn out?
Our guest for this episode played a pivotal role in helping one of the largest ketamine clinics in the world scale across several locations, so she’s got some invaluable perspective to share on these questions and more.
Meet Our Guest
Dr. Dominique Morisano, CPsych is a clinical psychologist, professor, and researcher living in Toronto, Canada.
She holds academic appointments at the University of Ottawa/University of Toronto (Adjunct Professor), Centre for Addiction and Mental Health (Affiliate Scientist), and Erasmus University Rotterdam (Visiting Scholar).
She has completed extensive training in psychedelic-assisted psychotherapies receiving the CIIS Certificate in Psychedelic Assisted Therapies and Research (2019), as well as targeted training for working with MDMA, psilocybin, and ketamine from MAPS, Compass, Polaris, Synthesis, Fluence, Beckley Retreats, and the Ketamine Training Center.
She is a Special Advisor at Field Trip Health, where she was previously Chief Psychologist (USA) and VP of Therapeutic Growth and Innovation (global) for 2 years.
She currently runs a trauma/addiction focused private practice in Toronto and NYC and consults for several companies in the psychedelic-therapies space.
She is a co-Founder and Chair of the Board of Psychedelics R2R, which was behind the recent hybrid, non-profit, and submissions-based psychedelics research conference “From Research to Reality: Global Summit on Psychedelic-Assisted Therapies and Medicine”.
She is dedicated to social justice, diversity, equity and inclusion in the psychedelic space and the study/use of psychedelic-assisted therapies for both personal growth and addressing human suffering.
Follow Dr. Dominique Morisano on Twitter here.
Connect with her through her website here.
Meet Our Host
Hey there!
I’m Sonia Stringer
I’m a passionate advocate for psychedelic-assisted therapy, & founder of Celebrating Women In Psychedelics
Sonia has a knack for leveraging technology & developing communities that create valuable learning & networking opportunities for members. She's previously built online communities of 500k+ members & is excited to utilize her skills to support women advancing the psychedelic sector.
A former Board Member of the Psychedelic Association of Canada (2020 -2022) she consults with psychedelic companies & develops training programs for health care professionals interested in learning more about the potential of psychedelic-assisted therapy.
Follow Sonia on LinkedIn Here
